OXGR1 and asthma: Bankova et al. proposed that OXGR1 is a high-affinity leukotriene E4 (LTE4) receptor, a stable cystic weak agonist that shrinks the smooth muscles of the airways but causes airflow obstruction and inflammation of the lungs in asthma patients [10].